Bedside test for bleeding prevention drug in heart surgery
Treatments studied
Part of Heart & circulation clinical trials.
This study tests a quick bedside measurement of how well the drug tranexamic acid works to prevent bleeding during heart surgery. It may help doctors give the right dose to reduce blood loss.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are scheduled for elective heart surgery (bypass, aortic valve replacement, or mitral valve surgery).
- Your kidneys are working normally (no severe kidney disease).
- You have not had a seizure in the past.
- You are not pregnant.
- You are not taking blood thinners (except aspirin) before surgery, and you can understand and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares different doses of tranexamic acid, a medicine that reduces bleeding, in patients having planned heart surgery with a heart-lung machine. It aims to find the best dose to prevent blood loss.
This trial tests two medicines—ACT (a blood thinner) and tranexamic acid (a medicine to reduce bleeding)—to see which is better at controlling bleeding during heart surgery. It is for adults having planned heart surgery with a heart-lung machine.
This study compares two ways of giving a medicine called tranexamic acid — as a pill or through an IV — to see which works better at reducing bleeding during heart bypass surgery. If you are having heart surgery without a heart-lung machine, this trial may help you recover with less bleeding.
This trial tests whether giving tranexamic acid through an IV during surgery can reduce bleeding in patients with high-risk conditions like obesity, heart problems, diabetes, or blood clotting issues. It may help make surgery safer for you.
This trial studies whether giving tranexamic acid (TXA) based on patient needs during heart surgery works better than a one-size-fits-all approach. It may help reduce bleeding during surgery, while monitoring for clotting-related side effects.
This trial tests whether tranexamic acid (a medicine that helps blood clot) can reduce blood loss during long spine surgery after an injury. It may help lower the chance of needing transfusions and manage surgical bleeding.
Hear when a new Antifibrinolytic Agents trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.